Skip to content

Solvac stock

SOLV.BRBRU

Solvac S.A., Basic MaterialsISIN BE0003545531

$95.30▼ $1.11 (−1.1%)Closing price of 12 Nov 2026

52Score 52 out of 100, Neutral

Turn on early warning

Price and trend

84 / 100

Price history

+1.2% in one year

The chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.

Long-term trend

Above the 200-day line: the price is 10% above it.

Trend change

Since August 2026 the 50-day line has been above the 200-day line; the trend has turned up.

Momentum

Normal: the price is neither overheated nor sold off (RSI 51).

Distance to the high

The price is 7.0% below its 52-week high. Largest decline in 20 years: 64% (May 2007 to March 2009).

Chart figures for advanced users
SMA 50$95.00
Average price of the last 50 trading days, shows the short-term trend.
SMA 200$86.57
Average price of the last 200 trading days, shows the long-term trend.
RSI (14)51
Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
MACDabove the signal line
Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
Support$70.92
The lowest closing price of the last twelve months.
Resistance$102.50
The highest closing price of the last twelve months.
Market cap
$2.04B
Div. yield
6.76%
12 months
14.8
Fair value
$50.59

Snapshot

Computed from the data by fixed rules, no AI

  • Solvac S.A. belongs to the Chemicals industry (Belgium) and, with a market value of $2.04B, is number 30 of 44 companies in its industry on MEQIRI.
  • In fiscal 2025 it reported revenue of $4.18K (down 24.6% year on year) and earnings of $138.86M (up 19.7%).
  • MEQIRI Score 52 out of 100 (Neutral): rank 296 of 461 in Basic Materials, median 57.
Show more
  • The P/E is 14.8 (Chemicals median 15.7, own median of recent years 12.9).
  • Our model puts fair value at $50.59, with the price 88% above it.

In plain words

The numbers on this page in plain words, written by an AI

Strengths

  • High marginNet margin 100% over the last 12 months, Chemicals median 0%.
  • High dividend yieldDividend yield 6.76%, Chemicals median 4.14%.

Weaknesses

  • Above fair valuePrice 88% above the fair value of $50.59.Valuation 40
  • Negative free cash flowFree cash flow −$3.16M over the last 12 months.Fundamentals 44
52/ 100
MEQIRI Score
Neutral

Its standout strengths are technical analysis and stability, while capital allocation and growth hold the score back.

Daily figure as of 13 Nov 2026

How the score is calculated

Score overview

Fundamental quality fluctuates.

Profit consistency90% of years
Cash conversion (free cash flow to earnings, 12 months)−2%
ROIC (12 months)−0.2%
Positive free cash flow70% of years
How this category is measured

Score history

The full history of up to 20 years comes with MEQIRI Pro.

See plans

Crash risk medium

How well MEQIRI warns

In the middle among smaller stocks.

From 2016 to 2025, 20 in 100 such stocks fell 30% or more within a year, against a group average of 23 in 100.

What drives the risk

  • weak fundamentals
  • cyclical sector (energy or materials), as a group, crashed more often in the backtest

What lowers it

  • price near its 52-week high

Valuation

Valuation signal

Significantly overvalued
Price
$95.30
Fair value
$50.59
Gap to fair value
+88%

In our model the price counts as cheap below $36.13 and expensive above $84.31 (uncertainty high, one part of the fair value is more than twice the other).

The two parts of the fair value come to $0.13 (cash-flow model) and $101.04 (industry comparison), and the gap between them shows how uncertain the estimate is.

Calculated with a cost of equity of 7.7%. At 8.7% the fair value would be $50.57, at 6.7% it would be $50.60.

Valuation metrics

no data
72.6
Fair value (model)
$50.59
Earnings part $101.04 (earnings per share $6.45 × 15.7)

Half from the dividend model, half from earnings times the industry P/E (15.7).

Calculate with your own assumptions

Company performance

This shows several years of history with an automatic assessment.

Revenue

14 years

In the twelve months to 30 Jun 2026, revenue fell 24.6% on the twelve months before. Revenue swung sharply, with 1 of 14 years negative. From 2012 revenue is reported differently (for example gross instead of net), so earlier years are not comparable and not shown.

Margins

14 years
  • Gross margin
  • Operating margin
  • Net margin

In fiscal 2025: gross −71392%, operating −104068%, net 3324813%. Last 12 months: net 100%. From 2012 revenue is reported differently (for example gross instead of net), so earlier years are not comparable and not shown.

Debt & balance sheet

latest quarter
0.06
39.5x
0.54
Cash & equivalents
$0

The balance sheet is solid, with low debt and comfortable interest coverage.

Earnings

Next earnings
No date announced.
Last reported
31 Jul 2026EPS reported $5.00

What happened at Solvac

The key events of the last six months from our own data. A click takes you to the matching card.

Sector comparison

461 rated companies in Basic Materials

Rank 296 of 461
296/ 461
This company
52
Sector median
57

Categories against the sector median

ProfitabilityMedian of 461 companies45 (median 49)4 below the median
GrowthMedian of 461 companies39 (median 54)15 below the median
FundamentalsMedian of 461 companies44 (median 65)21 below the median
ValuationMedian of 421 companies with a value40 (median 69)29 below the median
StabilityMedian of 461 companies75 (median 67)8 above the median
Capital allocationMedian of 461 companies40 (median 52)12 below the median
Technical analysisMedian of 461 companies84 (median 51)33 above the median
MomentumMedian of 461 companies59 (median 50)9 above the median

The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.

Competitors in Chemicals

The next larger and next smaller companies by market value

All 44 Chemicals stocks

Data status and sources

Score
Daily value of 13 Nov 2026, recalculated nightly
Price
Closing price of 12 Nov 2026
Latest annual report
Fiscal year 2025, period end 31 Dec 2025
Currency
Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = €0.9024)
Source
Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.

Mandatory disclosures for this rating

  • ; time horizon around 12 months
  • Rated Neutral, published since 7 Nov 2026 (in the score history since 6 Nov 2026)
  • Valuation signal Overvalued since 7 Nov 2026
  • End-of-day prices, metrics cached for up to 24 hours
  • Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
  • Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
  • Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.

MEQIRI counts visits without cookies. With your consent we remember for 90 days where you came from, also in your account, count page changes and time on page, recognise your next visit and load the Meta Pixel, which measures our advertising. You can withdraw your consent at any time under Cookie settings. Privacy